ArticleOncology letters2026

Long survival of PD-L1-positive mediastinal sarcomatoid carcinoma after immunotherapy and anti-angiogenic target therapy: A case report.

Shuling Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.